BRPI0408359A - derivados de fenilpiridazina solúveis em água e medicamentos contendo os mesmos - Google Patents
derivados de fenilpiridazina solúveis em água e medicamentos contendo os mesmosInfo
- Publication number
- BRPI0408359A BRPI0408359A BRPI0408359-8A BRPI0408359A BRPI0408359A BR PI0408359 A BRPI0408359 A BR PI0408359A BR PI0408359 A BRPI0408359 A BR PI0408359A BR PI0408359 A BRPI0408359 A BR PI0408359A
- Authority
- BR
- Brazil
- Prior art keywords
- same
- water
- medicines containing
- phenylpyridazine
- derivatives
- Prior art date
Links
- XWSSUYOEOWLFEI-UHFFFAOYSA-N 3-phenylpyridazine Chemical class C1=CC=CC=C1C1=CC=CN=N1 XWSSUYOEOWLFEI-UHFFFAOYSA-N 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 102000000589 Interleukin-1 Human genes 0.000 abstract 1
- 108010002352 Interleukin-1 Proteins 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"DERIVADOS DE FENILPIRIDAZINA SOLúVEIS EM áGUA E MEDICAMENTOS CONTENDO OS MESMOS". Um derivado de fenilpiridazina representado pela fórmula geral (1): (em que R1, R2, R3, X, Y, Z, e n são os mesmos como definidos na descrição) ou um sal do mesmo; e um medicamento contendo o derivado ou o sal. O derivado de fenilpiridazina tem excelente atividade inibitória contra a produção de interleucina-1<225> e tem alta solubilidade em água e alta absorvibilidade oral.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003073403 | 2003-03-18 | ||
PCT/JP2004/003487 WO2004083188A1 (ja) | 2003-03-18 | 2004-03-16 | 水溶性フェニルピリダジン誘導体及びこれを含有する医薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0408359A true BRPI0408359A (pt) | 2006-03-21 |
Family
ID=33027793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0408359-8A BRPI0408359A (pt) | 2003-03-18 | 2004-03-16 | derivados de fenilpiridazina solúveis em água e medicamentos contendo os mesmos |
Country Status (13)
Country | Link |
---|---|
US (1) | US7211577B2 (pt) |
EP (1) | EP1604984A1 (pt) |
JP (1) | JPWO2004083188A1 (pt) |
KR (1) | KR20050113627A (pt) |
CN (1) | CN1759103A (pt) |
AU (1) | AU2004221966A1 (pt) |
BR (1) | BRPI0408359A (pt) |
CA (1) | CA2518227A1 (pt) |
MX (1) | MXPA05009972A (pt) |
NO (1) | NO20053592L (pt) |
RU (1) | RU2005132167A (pt) |
TW (1) | TW200510335A (pt) |
WO (1) | WO2004083188A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004010207A1 (de) * | 2004-03-02 | 2005-09-15 | Aventis Pharma S.A. | Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate |
CN101296707A (zh) * | 2005-10-28 | 2008-10-29 | 兴和株式会社 | 类风湿性关节炎的预防和/或治疗方法 |
HUE035919T2 (en) * | 2013-02-07 | 2018-05-28 | Merck Patent Gmbh | Macrocyclic pyridazinone derivatives |
WO2014121931A1 (en) | 2013-02-07 | 2014-08-14 | Merck Patent Gmbh | Pyridazinone-amides derivatives |
FR3103701B1 (fr) * | 2019-11-28 | 2021-11-26 | Inst Nat Sante Rech Med | Composés de typen2-arylméthyl-4-haloalkyl-pyridazin-3-one et leur utilisation |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR206496A1 (es) | 1972-07-03 | 1976-07-30 | Riker Laboratories Inc | Procedimiento para la preparacion de 2-fenoxi-4-nitro-alquil o haloalquilsulfonanilidas |
JPH0753725B2 (ja) * | 1987-10-08 | 1995-06-07 | 富山化学工業株式会社 | 4h―1―ベンゾピラン―4―オン誘導体およびその塩、それらの製造法並びにそれらを含有する抗炎症剤 |
FI91062C (fi) | 1988-12-28 | 1994-05-10 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisten naftaleenijohdannaisten valmistamiseksi |
MX9300141A (es) | 1992-01-13 | 1994-07-29 | Smithkline Beecham Corp | Compuestos de imidazol novedosos, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
DE69408598T2 (de) | 1993-06-08 | 1998-09-17 | Vertex Pharmaceuticals Inc Cam | Pyridazine als Interleukin-1-beta Verwandlungsenzym Inhibitoren |
CA2228050A1 (en) | 1995-08-10 | 1997-02-20 | Harold G. Selnick | 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
CA2283399C (en) | 1997-03-14 | 2006-02-21 | Merck Frosst Canada & Co. | Pyridazinones as inhibitors of cyclooxygenase-2 |
JP2002511887A (ja) | 1997-08-22 | 2002-04-16 | アボツト・ラボラトリーズ | プロスタグランジンエンドペルオキシドhシンターゼ生合成阻害薬 |
EP1007515A1 (en) | 1997-08-22 | 2000-06-14 | Abbott Laboratories | Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors |
PT1043317E (pt) * | 1997-11-19 | 2009-05-11 | Kowa Co | Novos derivados de piridazina e fármacos que os contêm como ingrediente activo |
TWI241295B (en) * | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
CN1279026C (zh) | 1998-10-27 | 2006-10-11 | 艾博特公司 | ***素内过氧化物h合酶生物合成抑制剂 |
JP2000247959A (ja) * | 1999-02-26 | 2000-09-12 | Kowa Co | ピリダジン−3−オン誘導体及びこれを含有する医薬 |
US6664256B1 (en) * | 2000-07-10 | 2003-12-16 | Kowa Co., Ltd. | Phenylpyridazine compounds and medicines containing the same |
BR0212848A (pt) * | 2001-09-26 | 2004-08-17 | Kowa Co | Derivados fenilpiridazina hidrossolúveis e medicamentos contendo os mesmos |
US6861428B2 (en) * | 2001-09-26 | 2005-03-01 | Kowa Co., Ltd. | Water-soluble phenylpyridazine compounds and compositions containing the same |
RU2328495C2 (ru) | 2003-03-07 | 2008-07-10 | Кова Ко., Лтд. | Производное бензофурана |
-
2004
- 2004-03-16 US US10/544,881 patent/US7211577B2/en not_active Expired - Fee Related
- 2004-03-16 JP JP2005503698A patent/JPWO2004083188A1/ja active Pending
- 2004-03-16 CN CNA200480006774XA patent/CN1759103A/zh active Pending
- 2004-03-16 RU RU2005132167/04A patent/RU2005132167A/ru unknown
- 2004-03-16 MX MXPA05009972A patent/MXPA05009972A/es not_active Application Discontinuation
- 2004-03-16 KR KR1020057016226A patent/KR20050113627A/ko not_active Application Discontinuation
- 2004-03-16 AU AU2004221966A patent/AU2004221966A1/en not_active Abandoned
- 2004-03-16 EP EP04721008A patent/EP1604984A1/en not_active Withdrawn
- 2004-03-16 CA CA002518227A patent/CA2518227A1/en not_active Abandoned
- 2004-03-16 BR BRPI0408359-8A patent/BRPI0408359A/pt not_active IP Right Cessation
- 2004-03-16 WO PCT/JP2004/003487 patent/WO2004083188A1/ja active Application Filing
- 2004-03-18 TW TW093107278A patent/TW200510335A/zh unknown
-
2005
- 2005-07-25 NO NO20053592A patent/NO20053592L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1759103A (zh) | 2006-04-12 |
CA2518227A1 (en) | 2004-09-30 |
TW200510335A (en) | 2005-03-16 |
KR20050113627A (ko) | 2005-12-02 |
NO20053592L (no) | 2005-11-30 |
WO2004083188A1 (ja) | 2004-09-30 |
EP1604984A1 (en) | 2005-12-14 |
NO20053592D0 (no) | 2005-07-25 |
MXPA05009972A (es) | 2005-11-04 |
US20060142292A1 (en) | 2006-06-29 |
JPWO2004083188A1 (ja) | 2006-06-22 |
RU2005132167A (ru) | 2006-05-10 |
AU2004221966A1 (en) | 2004-09-30 |
US7211577B2 (en) | 2007-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
MA27040A1 (fr) | Nucleosides substitues en 4' | |
BRPI0412851A (pt) | benzamidazóis de n-metila-substituìdos | |
ATE349432T1 (de) | 2-anilino-pyrimidin-derivate als cyclin-abhängige kinase hemmer | |
NO20060973L (no) | Pyridylderivater og deres anvendelse som tempeutiske midler | |
MY134880A (en) | Thiazolyl amide derivatives | |
MXPA04004601A (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
TR200002605T2 (tr) | Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri | |
SE0300908D0 (sv) | Azaindole derivatives, preparations thereof, uses thereof and compositions containing them | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
BR0313727A (pt) | Derivados de isoquinolina como inibidores de metaloproteinase da matriz | |
MXPA05013050A (es) | Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos. | |
BRPI0413223A (pt) | artigo do vestuário descartável | |
SE0302570D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
PT1095040E (pt) | Novos benzoxazoles com actividade inibidora da pde | |
BRPI0408359A (pt) | derivados de fenilpiridazina solúveis em água e medicamentos contendo os mesmos | |
SE0302572D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
MXPA02004441A (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa. | |
TW200504059A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
BRPI0415034A (pt) | derivados de aminopiridina como inibidores de não-sintase induzìveis | |
AU2001285944A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
TW200510370A (en) | Urea derivatives | |
MXPA05012772A (es) | Derivados de benzotiazol y uso de los mismos en el tratamiento de enfermedades relacionadas con el receptor a2a de adenosina. | |
SE0300104D0 (sv) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
EP1325918A4 (en) | CARDIOUS CELL APOPTOSIS INHIBITORS AND TREATMENT / PREVENTION OF HEART DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |